Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data

The consensus molecular subtypes of colorectal cancer

Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · see citing works

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J., Schrama, J. G., Erdkamp, F., Vos, A. H., van Groeningen, C. J., Sinnige, H. A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808268 · Cited by 1,330 · see citing works

Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

Lugli, A., Kirsch, R., Ajioka, Y., Bosman, F. T., Cathomas, G., Dawson, H., Zimaity, H. E., Fléjou, J., Hansen, T. P., Hartmann, A., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.46 · Cited by 1,174 · see citing works

Mismatch Repair Status and <i>BRAF</i> Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772 · see citing works

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

De Sousa E Melo, F., Wang, X., Jansen, M., Fessler, E., Trinh, A., de Rooij, L. P. M. H., de Jong, J. H., de Boer, O. J., van Leersum, R., Bijlsma, M. F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3174 · Cited by 771 · see citing works

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Koopman, M., Antonini, N. F., Douma, J., Wals, J., Honkoop, A. H., Erdkamp, F., de Jong, R. S., Rodenburg, C. J., Vreugdenhil, G., Loosveld, O. J. L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61086-1 · Cited by 629 · see citing works

Tumor Budding: The Name is EMT. Partial EMT.

Grigore, A. D., Jolly, M. K., Jia, D., Farach‐Carson, M. C., & Levine, H. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5050051 · Cited by 493 · see citing works

Methylation of Cancer-Stem-Cell-Associated Wnt Target Genes Predicts Poor Prognosis in Colorectal Cancer Patients

Melo, F. D. S. E., Çolak, S., Buikhuisen, J. Y., Köster, J., Cameron, K., de Jong, J. H., Tuynman, J. B., Prasetyanti, P. R., Fessler, E., van den Bergh, S., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.10.008 · Cited by 333 · see citing works

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer

Rogers, A. C., Winter, D. C., Heeney, A., Gibbons, D., Lugli, A., Puppa, G., & Sheahan, K. D. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.274 · Cited by 243 · see citing works

Tumor budding in colorectal cancer—ready for diagnostic practice?

Koelzer, V. H., Zlobec, I., & Lugli, A. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.08.007 · Cited by 242 · see citing works

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab

Tol, J., Dijkstra, J. R., Klomp, M., Teerenstra, S., Dommerholt, M., Vink-Börger, M. E., van Cleef, P. H. J., van Krieken, J. H., Punt, C. J. A., & Nagtegaal, I. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.036 · Cited by 210 · see citing works

Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry

Trinh, A., Trumpi, K., De Sousa E Melo, F., Wang, X., de Jong, J. H., Fessler, E., Kuppen, P. J. K., Reimers, M. S., Swets, M., Koopman, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0680 · Cited by 180 · see citing works

Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching

De Smedt, L., Palmans, S., Andel, D., Govaere, O., Boeckx, B., Smeets, D., Galle, E., Wouters, J., Barras, D., Suffiotti, M., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.382 · Cited by 163 · see citing works

Molecular profiling of tumour budding implicates TGFβ‐mediated epithelial–mesenchymal transition as a therapeutic target in oral squamous cell carcinoma

Jensen, D., Dabelsteen, E., Specht, L., Fiehn, A. K., Therkildsen, M. H., Jønson, L., Vikesaa, J., Nielsen, F. C., & von Buchwald, C. (2015) · The Journal of Pathology · doi:10.1002/path.4550 · Cited by 129 · see citing works

Tumor Budding in Colorectal Carcinoma

Graham, R. P., Vierkant, R. A., Tillmans, L. S., Wang, A. H., Laird, P. W., Weisenberger, D. J., Lynch, C. F., French, A. J., Slager, S. L., Raissian, Y., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000504 · Cited by 122 · see citing works

Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patients

Lugli, A., Vlajnic, T., Giger, O., Karamitopoulou, E., Patsouris, E., Peros, G., Terracciano, L., & Zlobec, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.02.010 · Cited by 122 · see citing works

Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis

Cappellesso, R., Luchini, C., Veronese, N., Mele, M. L., Rosa-Rizzotto, E., Guido, E., Lazzari, F. D., Pilati, P., Farinati, F., Realdon, S., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.04.013 · Cited by 101 · see citing works

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer

Goossens-Beumer, I. J., Zeestraten, E. C. M., Benard, A., Christen, T., Reimers, M. S., Keijzer, R., Sier, C. F. M., Liefers, G., Morreau, H., Putter, H., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.226 · Cited by 94 · see citing works

Detailed analysis of epithelial‐mesenchymal transition and tumor budding identifies predictors of long‐term survival in pancreatic ductal adenocarcinoma

Kohler, I., Bronsert, P., Timme, S., Werner, M., Brabletz, T., Hopt, U. T., Schilling, O., Bausch, D., Keck, T., & Wellner, U. F. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12752 · Cited by 93 · see citing works

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer

Galván, J. A., Stüssi‐Helbling, M., Koelzer, V. H., Tschan, M. P., Berger, M. D., Hädrich, M., Schnüriger, B., Karamitopoulou, E., Dawson, H., Inderbitzin, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2716 · Cited by 72 · see citing works

High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations

Prall, F., & Ostwald, C. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.04.002 · Cited by 57 · see citing works

Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients

Zlobec, I. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i38.4823 · Cited by 52 · see citing works

KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases

Barresi, V., Bonetti, L. R., & Bettelli, S. R. (2015) · Pathology · doi:10.1097/pat.0000000000000300 · Cited by 38 · see citing works

KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer

Cho, Y., Cha, P.-H., Kaduwal, S., Park, J.-C., Lee, S. G., Yoon, J.-S., Shin, W., Kim, H., Ro, E. J., Koo, K.-H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13172 · Cited by 34 · see citing works

KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior

Jang, S.-J., Hong, M. E., Shin, M. K., Kim, B. C., Shin, H.-S., Yu, E., Hong, S., Kim, J., Chun, S., Kim, T., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.01.010 · Cited by 34 · see citing works

Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab

van Dijk, E., Biesma, H. D., Cordes, M., Smeets, D., Neerincx, M., Das, S., Eijk, P. P., Murphy, V., Barat, A., Bacon, O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.1782 · Cited by 33 · see citing works

Prognostic Impact of Tumor-Budding Grade in Stages 1–3 Colon Cancer: A Retrospective Cohort Study

Oh, B. Y., Park, Y. A., Huh, J. W., Yun, S. H., Kim, H. C., Chun, H.-K., Kim, S. H., Ha, S. Y., Lee, W. Y., & Cho, Y. B. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6135-5 · Cited by 31 · see citing works

High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer

van den Broek, E., Dijkstra, M. J. J., Krijgsman, O., Sie, D., Haan, J. C., Traets, J. J. H., van de Wiel, M. A., Nagtegaal, I. D., Punt, C. J. A., Carvalho, B. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138141 · Cited by 29 · see citing works

MicroRNA-200b is downregulated in colon cancer budding cells

Nguyen, K., Lindebjerg, J., Nielsen, B. S., Hansen, T. F., & Sørensen, F. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178564 · Cited by 28 · see citing works

DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they derive

Centeno, I., Paasinen-Sohns, A., Flury, M., Galván, J. A., Zahnd, S., Koelzer, V. H., Sokol, L., Dawson, H., Lugli, A., Cathomas, G., et al. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2071-9 · Cited by 15 · see citing works

Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer

Lee, H., Hong, Y., Etlioglu, H. E., Cho, Y. B., Pomella, V., den Bosch, B. V., Vanhecke, J., Verbandt, S., Hong, H.-K., Min, J.-W., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0636-z · Cited by 916 · see citing works

Tumour budding in solid cancers

Lugli, A., Zlobec, I., Berger, M. D., Kirsch, R., & Nagtegaal, I. D. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0422-y · Cited by 372 · see citing works

Pathological Features and Prognostication in Colorectal Cancer

Chen, K., Collins, G. P., Wang, H., & Toh, J. W. T. (2021) · Current Oncology · doi:10.3390/curroncol28060447 · Cited by 248 · see citing works

Clinical value of consensus molecular subtypes in colorectal cancer: a systematic review and meta-analysis

ten Hoorn, S., de Back, T. R., Sommeijer, D. W., & Vermeulen, L. (2022) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab106 · Cited by 203 · see citing works

How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement

Nagtegaal, I. D., & Glynne‐Jones, R. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.101964 · Cited by 99 · see citing works

Investigation of colorectal cancer in accordance with consensus molecular subtype classification

Sawayama, H., Miyamoto, Y., Ogawa, K., Yoshida, N., & Baba, H. (2020) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12362 · Cited by 60 · see citing works

Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)

Lee, H., Sha, D., Foster, N. R., Shi, Q., Alberts, S. R., Smyrk, T. C., & Sinicrope, F. A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.01.011 · Cited by 67 · see citing works

Molecular features and gene expression signature of metastatic colorectal cancer (Review)

Poturnajova, M., Furielova, T., Balintova, S., Schmidtova, S., Kučerová, L., & Matúšková, M. (2021) · Oncology Reports · doi:10.3892/or.2021.7961 · Cited by 65 · see citing works

RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer

Maffeis, V., Nicolè, L., & Cappellesso, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01255 · Cited by 63 · see citing works

Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters

Pai, R. K., Hartman, D. J., Schaeffer, D. F., Rosty, C., Shivji, S., Kirsch, R., & Pai, R. K. (2021) · Histopathology · doi:10.1111/his.14353 · Cited by 58 · see citing works

Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma

Meyer, S. N., Galván, J. A., Zahnd, S., Sokol, L., Dawson, H., Lugli, A., & Zlobec, I. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.02.002 · Cited by 48 · see citing works

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

Basile, D., Broudin, C., Emile, J. F., Falcoz, A., Pagès, F., Mineur, L., Bennouna, J., Louvet, C., Artru, P., Fratte, S., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.03.002 · Cited by 47 · see citing works

Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine

Mouillet-Richard, S., Cazelles, A., Sroussi, M., Gallois, C., Taieb, J., & Laurent-Puig, P. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3964 · Cited by 43 · see citing works

Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival

Pai, R. K., Banerjee, I., Shivji, S., Jain, S., Hartman, D., Buchanan, D. D., Jenkins, M. A., Schaeffer, D. F., Rosty, C., Como, J., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.08.025 · Cited by 43 · see citing works

Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer

Georges, L. M. C., Wever, O. D., Galván, J. A., Dawson, H., Lugli, A., Demetter, P., & Zlobec, I. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00139 · Cited by 43 · see citing works

Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer

Zlobec, I., Bächli, M., Galuppini, F., Berger, M. D., Dawson, H., Nagtegaal, I. D., & Lugli, A. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03090-w · Cited by 36 · see citing works

Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology

Reitsam, N. G., Grozdanov, V., Loeffler, C. M. L., Muti, H. S., Grosser, B., Kather, J. N., & Märkl, B. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00695-y · Cited by 35 · see citing works

ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing

Buechler, S. A., Stephens, M., Hummon, A. B., Ludwig, K. R., Cannon, E. E., Carter, T. C., Resnick, J. M., Gökmen‐Polar, Y., & Badve, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-69083-y · Cited by 34 · see citing works

Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer

Källberg, J., Harrison, A., March, V., Bērziņa, S., Nemazanyy, I., Kepp, O., Kroemer, G., Mouillet‐Richard, S., Laurent‐Puig, P., Taly, V., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05806-z · Cited by 31 · see citing works

Intratumoral metabolic heterogeneity of colorectal cancer

Hirose, Y., & Taniguchi, K. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2021 · Cited by 30 · see citing works

KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis‐free survival and reduced E‐cadherin expression

Tanaka, M. H., Kunita, A., Yamagishi, M., Katoh, H., Ishikawa, S., Yamamoto, H., Abe, J., Arita, J., Hasegawa, K., Shibata, T., et al. (2022) · Liver International · doi:10.1111/liv.15366 · Cited by 23 · see citing works

Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts

Guil‐Luna, S., Mena‐Osuna, R., Navarrete‐Sirvent, C., Lopez-Sanchez, L. M., Khouadri, K., Toledano‐Fonseca, M., Mantrana, A., Guler, I., Villar, C., Díaz, C., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00264 · Cited by 21 · see citing works

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining

Blank, A., Schenker, C., Dawson, H., Beldi, G., Zlobec, I., & Lugli, A. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00247 · Cited by 21 · see citing works

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer

Nguyen, H.-G., Lundström, O., Blank, A., Dawson, H., Lugli, A., Anisimova, M. O., & Zlobec, I. (2021) · Modern Pathology · doi:10.1038/s41379-021-00894-8 · Cited by 20 · see citing works

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma

Hou, Y., Wang, W., Zeng, Z., Gan, W., Lv, S., Li, T., Yan, Z., Zhang, R., & Yang, M. H. (2020) · Aging · doi:10.18632/aging.104038 · Cited by 19 · see citing works

How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells

Díaz, M. B. N., Carriere, P., & Gentili, C. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i5.281 · Cited by 19 · see citing works

Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps

Brown, I., Zammit, A. P., Bettington, M. L., Cooper, C. L., Gill, A. J., Agoston, A., & Odze, R. D. (2023) · Histopathology · doi:10.1111/his.14970 · Cited by 17 · see citing works

Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes

Adam, R., Poel, D., Moreno, L. F., Spronck, J., de Back, T. R., Torang, A., Barila, P. M. G., ten Hoorn, S., Markowetz, F. M., Wang, X., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13210 · Cited by 17 · see citing works

Molecular characterization of “sessile serrated” adenoma to carcinoma transition in six early colorectal cancers

Cappellesso, R., Mele, M. L., Munari, G., Rosa-Rizzotto, E., Guido, E., Lazzari, F. D., Pilati, P., Tonello, M., Farinati, F., Realdon, S., et al. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.02.001 · Cited by 14 · see citing works

Prognostic and predictive values of tumour budding in stage IV colorectal cancer

Nagata, K., Shinto, E., Yamadera, M., Shiraishi, T., Kajiwara, Y., Okamoto, K., Mochizuki, S., Hase, K., Kishi, Y., & Ueno, H. (2020) · BJS Open · doi:10.1002/bjs5.50300 · Cited by 14 · see citing works

Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition

Maffeis, V., Cappellesso, R., Galuppini, F., Guzzardo, V., Zanon, A., Cazzador, D., Emanuelli, E., Ventura, L., Martini, A., & Fassina, A. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02748-1 · Cited by 14 · see citing works

Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy

Guil‐Luna, S., Rivas‐Crespo, A., Navarrete‐Sirvent, C., Mantrana, A., Pera, A., Mena‐Osuna, R., Toledano‐Fonseca, M., García‐Ortiz, M. V., Villar, C., Sánchez-Montero, M. T., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115592 · Cited by 13 · see citing works

Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

ten Hoorn, S., Waasdorp, C., van Oijen, M. G. H., Damhofer, H., Trinh, A. C., Zhao, L., Smits, L. J. H., Bootsma, S., van Pelt, G. W., Mesker, W. E., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09436-0 · Cited by 13 · see citing works

Assessing genotype−phenotype correlations in colorectal cancer with deep learning: a multicentre cohort study

Gustav, M., van Treeck, M., Reitsam, N. G., Carrero, Z. I., Loeffler, C. M. L., Meneghetti, A. R., Märkl, B., Boardman, L. A., French, A. J., Goode, E. L., et al. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.100891 · Cited by 14 · see citing works

Clinicopathological Significances and Prognostic Role of Intratumoral Budding in Colorectal Cancers

Kang, G., Pyo, J., Kim, N. Y., & Kang, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195540 · Cited by 12 · see citing works

New Histoprognostic Factors to Consider for the Staging of Colon Cancers: Tumor Deposits, Invasive Tumor Infiltration and High-Grade Budding

Riffet, M., Dupont, B., Faisant, M., Cerasuolo, D., Menahem, B., Alvès, A., Dubois, F., Levallet, G., & Bazille, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043573 · Cited by 12 · see citing works

Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma

Marinović, S., Škrtić, A., Ivković, T. C., Poljak, M., & Kapitanović, S. (2021) · Human Cell · doi:10.1007/s13577-021-00576-2 · Cited by 11 · see citing works

Impact of the Microenvironment on Tumour Budding in Colorectal Cancer.

Georges, L. M. C., Verset, L., Zlobec, I., Demetter, P., & de Wever, O. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-02771-1_7 · Cited by 8 · see citing works

The battle for prognosis at the invasive front of colorectal cancer

Lugli, A., & Zlobec, I. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102918 · Cited by 10 · see citing works

A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer

Bueno-Fortes, S., Muenzner, J. K., Berral-González, A., Hampel, C., Lindner, P., Berninger, A., Huebner, K., Kunze, P., Bäuerle, T., Erlenbach‐Wuensch, K., et al. (2021) · Cancers · doi:10.3390/cancers14010136 · Cited by 9 · see citing works

Molecular pathology of colorectal cancer

Noack, P., & Langer, R. (2023) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-023-00893-2 · Cited by 9 · see citing works

Machine Learning and Radiomics Analysis for Tumor Budding Prediction in Colorectal Liver Metastases Magnetic Resonance Imaging Assessment

Granata, V., Fusco, R., Brunese, M. C., Ferrara, G., Tatangelo, F., Ottaiano, A., Avallone, A., Miele, V., Normanno, N., Izzo, F., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14020152 · Cited by 9 · see citing works

The Importance of Being “That” Colorectal pT1: A Combined Clinico-Pathological Predictive Score to Improve Nodal Risk Stratification

Gambella, A., Falco, E. C., Benazzo, G. M., Osella‐Abate, S., Senetta, R., Castellano, I., Bertero, L., & Cassoni, P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.837876 · Cited by 9 · see citing works

Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC

Wu, C. S.-Y., Pai, R. K., Kosiorek, H., Banerjee, I., Pfeiffer, A., Hagen, C. E., Hartley, C., Graham, R. P., Sonbol, M. B., Bekaii‐Saab, T., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3211 · Cited by 8 · see citing works

Implications for the colorectal surgeon following the 100 000 Genomes Project

McDermott, F. D., Newton, K., Beggs, A. D., & Clark, S. K. (2021) · Colorectal Disease · doi:10.1111/codi.15539 · Cited by 8 · see citing works

Differential CMS-Related Expression of Cell Surface Carbonic Anhydrases IX and XII in Colorectal Cancer Models—Implications for Therapy

Rotermund, A., Brandt, S., Staege, M. S., Luetzkendorf, J., Mueller, L. P., & Mueller, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065797 · Cited by 8 · see citing works

Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer

Lu, Y., Gu, D., Zhao, C., Sun, Y., Li, W., He, L., Wang, X., Kou, Z., Jiang, S., & Guo, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160052 · Cited by 7 · see citing works

Potential clinical scenarios of tumour budding in colorectal cancer.

Dawson, H., Blank, A., Zlobec, I., & Lugli, A. (2019) · PubMed · Cited by 7 · see citing works

Endoscopic and pathological characteristics of de novo colorectal cancer: Retrospective cohort study

Li, S.-Y., Yang, M.-Q., Liu, Y.-M., Sun, M.-J., & Zhang, H. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i18.2836 · Cited by 7 · see citing works

Endosomal pH is an evolutionarily conserved driver of phenotypic plasticity in colorectal cancer

Prasad, H., Harshavardhan, B. V., Subbalakshmi, A. R., Mandal, S., Jolly, M. K., & Visweswariah, S. S. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00463-0 · Cited by 6 · see citing works

Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients

Agy, F. E., Bardai, S. E., Bouguenouch, L., Lahmidani, N., Abkari, M. E., Benjelloun, E. B., Ousadden, A., Mazaz, K., ImaneToughrai, Ibrahimi, S. A., et al. (2022) · International Journal of Surgical Oncology · doi:10.1155/2022/9334570 · Cited by 6 · see citing works

Prognostic significance of p16, p21, and Ki67 expression at the invasive front of colorectal cancers

Kin, R., Hoshi, D., Fujita, H., Kosaka, T., Takamura, H., & Kiyokawa, E. (2022) · Pathology International · doi:10.1111/pin.13295 · Cited by 6 · see citing works

Intratumoral Budding and CD8-Positive T-cell Density in Pretreatment Biopsies as a Predictor of Response to Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer

Sano, S., Akiyoshi, T., Yamamoto, N., Hiyoshi, Y., Mukai, T., Yamaguchi, T., Nagasaki, T., Taketomi, A., Fukunaga, Y., & Kawachi, H. (2023) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2023.07.004 · Cited by 6 · see citing works

Embryonic Signaling Pathways Shape Colorectal Cancer Subtypes: Linking Gut Development to Tumor Biology

Toews, K. P., Auld, F. M., & Moyana, T. N. (2025) · Pathophysiology · doi:10.3390/pathophysiology32040052 · Cited by 5 · see citing works

KRAS Gene Mutation Associated with Grade of Tumor Budding and Peripheral Immunoinflammatory Indices in Patients with Colorectal Cancer

Liu, L., Guo, X., Ye, W., & Liu, Y. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s487525 · Cited by 5 · see citing works

Associations of Biomarkers of Systemic Inflammation, Angiogenesis, and Cell‐to‐Cell Adhesion With Tumor Budding Among Early‐Onset and Later‐Onset Colorectal Cancer Patients

Hausmann, O., Schobert, P. P., Ose, J., Himbert, C., Pletneva, M., Jedrzkiewicz, J., Nguyen, A., Lin, T., Warby, C. A., Hardikar, S. S., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.71267 · Cited by 5 · see citing works

Tumor microenvironment characteristics association with clinical outcome in patients with resected intestinal-type gastric cancer

Tian, C.-F., Jing, H., Sinicrope, F. A., Wang, J., Gao, B., Sun, X., Yao, Z., Li, L., Saberzadeh-Ardestani, B., Song, W., et al. (2024) · The Oncologist · doi:10.1093/oncolo/oyae124 · Cited by 5 · see citing works

Deep Learning and Colon Cancer Interpretation

McHugh, K. E., & Pai, R. K. (2023) · Surgical pathology clinics · doi:10.1016/j.path.2023.05.003 · Cited by 4 · see citing works

Predicting survival and prognosis in early-onset locally advanced colon cancer: a retrospective observational study

Chen, B., Ma, Y., Zhou, J., Gao, S., Yu, W., Yang, Y., Wang, Y., Ren, J., & Wang, D. (2023) · International Journal of Colorectal Disease · doi:10.1007/s00384-023-04543-1 · Cited by 4 · see citing works

Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and Recurrence

Pai, R. K., Eslinger, C. R., Lee, K. S., Farchoukh, L. O., Walden, D. M., Emiloju, O. E., Storandt, M. H., Hagen, C. E., Pfeiffer, A., Sonbol, M. B., et al. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104187 · Cited by 4 · see citing works

Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients

van de Weerd, S., Smit, M. A., Roelands, J. P., Mesker, W. E., Bedognetti, D., Kuppen, P. J. K., Putter, H., Tollenaar, R. A. �. �., Roodhart, J. M. L., Hendrickx, W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012707 · Cited by 4 · see citing works

Tumor Budding, p53, and DNA Mismatch Repair Markers in Sinonasal Intestinal-Type Adenocarcinoma: A Retrospective Study Supports the Adverse Prognostic Impact of Tumor Budding

Puccio, S., Azzarello, G., Maffeis, V., Laurino, L., Mairani, E., Conte, F. P., Tessari, N., Cazzador, D., Zanoletti, E., Politi, D., et al. (2024) · Cancers · doi:10.3390/cancers16101895 · Cited by 3 · see citing works

Significance of mucin-suspended tumor bud-like structures in colorectal cancer

Äijälä, V. K., Sirniö, P., Elomaa, H., Karjalainen, H., Kastinen, M., Tapiainen, V. V., Ahtiainen, M., Helminen, O., Wirta, E., Rintala, J. M. J., et al. (2025) · Human Pathology · doi:10.1016/j.humpath.2025.105772 · Cited by 3 · see citing works

Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer

Akabane, S., Shimizu, W., Takakura, Y., Kochi, M., Taguchi, K., Nakashima, I., Sato, K., Hattori, M., Egi, H., Sentani, K., et al. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01917-9 · Cited by 3 · see citing works

Extended tumor area-based stratification score combining tumor budding and stroma identifies a high-risk, immune-depleted group in localized microsatellite-stable colon cancer patients

de Lucas, B. P., Heras, B., Tarazona, N., Ortega, M., Huerta, M., Moro, D., Roselló, S., Roda, D., Pla, V., Cervantes, A. M. R., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155871 · Cited by 2 · see citing works

Two immune‐enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I–II colonic carcinoma

Tang, D., Huang, W., Zhu, Y., Wu, X., Sang, X., Wang, K., Cao, G., & Hao, M. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22703 · Cited by 2 · see citing works

Prognostic Impact of Tumor Budding on Moroccan Colon Cancer PatientsPreprint

Agy, F. E., Bardai, S. E., Bouguenouch, L., Lahmidani, N., Abkari, M. E., Benjelloun, E. B., Ousadden, A., Mazaz, K., Taughrai, I., Ibrahimi, S. A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-546470/v1 · Cited by 2 · see citing works

Whole-Slide ECM Imaging Reveals Dense Fibrous Matrix as a High-Risk Factor for Recurrence in Stage II Colon CancerPreprint

Ravensbergen, C. J., Colaco, V. S., Putter, H., Crobach, A. S. L. P., Boonstra, J. J., Lindeman, J. H. N., Tollenaar, R. A. �. �., & Mesker, W. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.14.622985 · Cited by 2 · see citing works

Independent prognostic significance of tumor budding and poorly differentiated clusters in Brazilian patients with stage II colorectal cancer

Reis, M. T., Matsushita, M. D. M., dos Santos, W., Berardinelli, G. N., Teodoro, V. A., dos Reis, M. B., Guimarães, D. P., & Reis, R. M. (2025) · Surgical and Experimental Pathology · doi:10.1186/s42047-025-00196-2 · Cited by 1 · see citing works

COLORECTAL MOLECULAR SUBTYPES – PROGRESS OR DEADLOCK?

Fedyanin, M. Y., Ignatova, E. O., & Tryakin, А. А. (2021) · Practical oncology · doi:10.31917/2201072 · Cited by 1 · see citing works

Outcome Prediction in Rectal Cancer Beyond the Current TNM System—An Unmet Need

Rodriguez‐Justo, M. (2023) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000003127 · Cited by 1 · see citing works

Clinicopathological features of colon cancer depending on the dMMR status of the tumor

Naumov, S. S., Krakhmal, N. V., Tarasov, M. N., Taranenko, M. I., Удут, Е. В., Kolobovnikova, Y. V., & Vtorushin, S. V. (2024) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2023-4-57-64 · Cited by 1 · see citing works

Histopathological features have limited correlation with gene expression-based classifiersPreprint

van de Weerd, S., Smit, M. A., Roelands, J. P., Mesker, W. E., Bedognetti, D., Kuppen, P. J. K., Putter, H., Tollenaar, R. A. �. �., Roodhart, J. M. L., Hendrickx, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1874959/v1 · Cited by 1 · see citing works

Assessing Genotype-Phenotype Correlations with Deep Learning in Colorectal Cancer: A Multi-Centric StudyPreprint

Gustav, M., van Treeck, M., Reitsam, N. G., Carrero, Z. I., Loeffler, C. M. L., Meneghetti, A. R., Märkl, B., Boardman, L. A., French, A. J., Goode, E. L., et al. (2025) · medRxiv · doi:10.1101/2025.02.04.25321660 · Cited by 1 · see citing works

Development and application of bioinformatic methods to analyze genome-wide expression and survival data from cancer patients

Bueno-Fortes, S. (2019) · doi:10.14201/gredos.140370

Therapierelevante histomorphologische und molekularpathologische Befunde beim Kolonkarzinom

Bläker, H. (2020) · Der Onkologe · doi:10.1007/s00761-020-00866-8

Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations and outcome in Stage I-II colonic carcinoma.Preprint

Tang, D., Huang, W., Yang, Z., Wu, X., Sang, X., Wang, K., Cao, G., & Hao, M. (2020) · doi:10.21203/rs.2.23306/v1

The implications of COX-2 and HER2 protein expression for the prognosis of colorectal cancer patients: An exploratory study from the North African region

Agy, F. E., Bahja, S., Abkari, M. E., Ibrahimi, S. A., Rhazi, K. E., Chbani, L., & Lahmidani, N. (2025) · Revista Española de Patología · doi:10.1016/j.patol.2025.100840

Additional file 1 of Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

ten Hoorn, S., Waasdorp, C., van Oijen, M. G. H., Damhofer, H., Trinh, A., Zhao, L., Smits, L. J. H., Bootsma, S., van Pelt, G. W., Mesker, W. E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19586860

Tumor‐Associated Fusobacterium nucleatum and Aggressive Architectural Features in Stage II Colorectal Cancer

dos Reis, M. B., Reis, M. T., Matsushita, M. D. M., Berardinelli, G. N., Cheregatto, T. C., Hirai, W. Y., Teodoro, V. A., Guimarães, D. P., & Reis, R. M. (2026) · Apmis · doi:10.1111/apm.70225

Characteristics of small early colorectal cancer in the non-pedunculated lesions and its relationship with the depth of invasion

Li, Y.-B., Song, W., Zhao, W.-J., Liu, H., Li, X.-Y., & Yin, X.-Y. (2026) · BMC Gastroenterology · doi:10.1186/s12876-026-05094-9

The molecular pathological basis and potential clinical applications of ‘zero‐budding’ status in stage II colorectal cancer

Liu, Y.-N., Wang, B., & Xu, Q. (2026) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.70120

Tumor Budding in Colorectal Cancer: Biological Basis, Clinical Risk Stratification, and Digital Pathology

Bernal, E., Martínez‐Díaz, F., & Garcı́a-Molina, F. (2026) · Cancers · doi:10.3390/cancers18213493

Endoscopic and pathological characteristics of de novo colorectal cancer: Retrospective cohort study

Li, S.-Y., Yang, M.-Q., Liu, Y.-M., Sun, M.-J., & Zhang, H. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i18.2836 · Cited by 7 · see citing works

Systematic review of tumour budding and association with common mutations in patients with colorectal cancer

Hatthakarnkul, P., Quinn, J. A., Matly, A., Ammar, A., Wyk, H. C. V., McMillan, D., & Edwards, J. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103490 · Cited by 12 · see citing works

Tumour budding in solid cancers.

Lugli, A., Zlobec, I., Berger, M. D., Kirsch, R., & Nagtegaal, I. D. (2021) · Open Access CRIS of the University of Bern · doi:10.7892/boris.147566

The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer

Zlobec, I., Bihl, M., Foerster, A., Rufle, A., & Lugli, A. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04273.x · Cited by 39 · see citing works

Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients

Agy, F. E., Bardai, S. E., Bouguenouch, L., Lahmidani, N., Abkari, M. E., Benjelloun, E. B., Ousadden, A., Mazaz, K., Taughrai, I., Ibrahimi, S. A., et al. (2021) · Greater South Information System · doi:10.60692/5qasw-sbc77